KLRB1 and cancer: In a previous study, Gentles et al. and his team (2015) came to the conclusion that KLRB1 is a significantly favorable prognostic indicator as reported in pan-cancer studies as well as a marker suggesting the characteristics of enhanced innate immunity among diverse T cell subsets (Fergusson et al., 2014).